Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
( )
While Mounjaro was initially approved for diabetes, the active ingredient (Tirzepatide) is widely prescribed off-label for weight management in patients without diabetes
Step-by-Step Reconstitution Protocol Step 1: Sanitize the rubber stopper of the lyophilized vial using alcohol swabs, employing circular motions from center outward
Long-term strategy: Weight regain after stopping GLP-1s is well-documented
Furthermore, there may be concerns regarding the long-term safety profile and uncommon adverse effects associated with GLP-1 receptor agonists, which may limit their use in specific patient populations
It remains in active Phase 3 development, with Eli Lilly targeting an NDA filing later in 2026 based on the TRIUMPH-1 and TRIUMPH-4 data reported so far
US$ 26.51
US$ 20.03
US$ 26.52
US$ 27.93
US$ 20.94
US$ 22.11
US$ 20.71
US$ 25.16
US$ 20.81
